Development of Smoothened Agonist Nonphospholipid Liposomal Nanoparticles for Bone Repair
Abstract
Non-healing bone injuries represent a source of morbidity for combat casualties and military veterans, exacting both a devastating individual toll on the lives affected as well as an enormous socioeconomic burden. The manipulation of Hedgehog(Hh) signaling is a promising alternative for improved bone regeneration. In particular, the Hh activating small molecule SAG targets bone and vascular formation to induce bone healing. The present study seeks to develop a nanoparticle packaged Hh small molecule for use as a widely applicable bone graft substitute. To achieve this, we developed a novel class of liposomes formulated with single-chain amphiphiles and high content of sterols (sterosomes), resulting in significantly increased nanoparticle stability compared to conventional phospholipid. The validity of sterosome nanoparticles, along with the addition of SAG, was ensured by hydrodynamic characterizations before progression to scaffold loading and in vivo application. SAG-loaded sterosome was consistently bioactive and its osteoinductive potential was verified. We then developed a strategy to immobilize sterosome onto the surface of poly (lactic-co-glycolic acid) scaffolds using dopamine intermediates to achieve controlled drug delivery in the defect site. The sterosome-immobilized scaffolds significantly improved osteogenesis through activation of Hh signaling pathway. This study suggests a useful therapeutic biomaterial design for clinical bone repair.
Document Details
- Document Type
- Technical Report
- Publication Date
- Aug 01, 2020
- Accession Number
- AD1114606
Entities
People
- Min Lee
Organizations
- University of California, Los Angeles